Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $271,273 - $301,259
-2,635 Reduced 3.03%
84,240 $8.67 Million
Q2 2023

Jul 20, 2023

SELL
$108.61 - $118.38 $592,901 - $646,236
-5,459 Reduced 5.91%
86,875 $10 Million
Q1 2023

Apr 27, 2023

BUY
$102.94 - $114.86 $397,348 - $443,359
3,860 Added 4.36%
92,334 $9.82 Million
Q4 2022

Feb 01, 2023

SELL
$87.44 - $112.11 $131,859 - $169,061
-1,508 Reduced 1.68%
88,474 $9.81 Million
Q3 2022

Nov 04, 2022

BUY
$84.53 - $94.96 $8,114 - $9,116
96 Added 0.11%
89,982 $7.75 Million
Q2 2022

Jul 20, 2022

SELL
$83.49 - $94.64 $131,246 - $148,774
-1,572 Reduced 1.72%
89,886 $8.2 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $671,366 - $752,559
-9,133 Reduced 9.08%
91,458 $7.5 Million
Q4 2021

Feb 01, 2022

SELL
$72.28 - $90.54 $6.63 Million - $8.31 Million
-91,732 Reduced 47.7%
100,591 $7.71 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $1.06 Million - $1.16 Million
-14,777 Reduced 7.14%
192,323 $14.4 Million
Q2 2021

Aug 10, 2021

SELL
$70.31 - $77.77 $2.01 Million - $2.23 Million
-28,619 Reduced 12.14%
207,100 $16.1 Million
Q1 2021

May 12, 2021

SELL
$68.86 - $81.11 $1.33 Million - $1.57 Million
-19,370 Reduced 7.59%
235,719 $18.2 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $1.72 Million - $1.91 Million
24,003 Added 10.39%
255,089 $20.9 Million
Q3 2020

Nov 09, 2020

SELL
$73.18 - $82.95 $1.12 Million - $1.27 Million
-15,333 Reduced 6.22%
231,086 $19.2 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $17.4 Million - $19.7 Million
246,419 New
246,419 $19.1 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track River Road Asset Management, LLC Portfolio

Follow River Road Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Road Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Road Asset Management, LLC with notifications on news.